431 related articles for article (PubMed ID: 35937696)
1. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis.
Paes Leme AF; Yokoo S; Normando AGC; Ormonde JVS; Domingues RR; Cruz FF; Silva PL; Souza BSF; Dos Santos CC; Castro-Faria-Neto H; Martins CM; Lopes-Pacheco M; Rocco PRM
Cytotherapy; 2024 May; 26(5):444-455. PubMed ID: 38363248
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
[TBL] [Abstract][Full Text] [Related]
4. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
Kreimer S; Ivanov AR
Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease.
Helin T; Palviainen M; Lemponen M; Maaninka K; Siljander P; Joutsi-Korhonen L
Platelets; 2024 Dec; 35(1):2313362. PubMed ID: 38380806
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
[TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins.
Karimi N; Cvjetkovic A; Jang SC; Crescitelli R; Hosseinpour Feizi MA; Nieuwland R; Lötvall J; Lässer C
Cell Mol Life Sci; 2018 Aug; 75(15):2873-2886. PubMed ID: 29441425
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone.
Gidlöf O; Evander M; Rezeli M; Marko-Varga G; Laurell T; Erlinge D
Sci Rep; 2019 Jun; 9(1):8991. PubMed ID: 31222168
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Puhm F; Allaeys I; Lacasse E; Dubuc I; Galipeau Y; Zaid Y; Khalki L; Belleannée C; Durocher Y; Brisson AR; Wolberg AS; Langlois MA; Flamand L; Boilard E
Blood Adv; 2022 Jun; 6(12):3593-3605. PubMed ID: 35443030
[TBL] [Abstract][Full Text] [Related]
11. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
Hisada Y; Sachetto ATA; Mackman N
Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of aspergillus flavus endophthalmitis derived extracellular vesicles in an in-vivo murine model.
Gandhi J; Naik MN; Mishra DK; Joseph J
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36002004
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID-19 and neurological symptoms.
Taxiarchis A; Bellander BM; Antovic J; Soutari N; Virhammar J; Kumlien E; Karakoyun C; Rostami E; Antovic A
Int J Lab Hematol; 2024 Feb; 46(1):42-49. PubMed ID: 37795549
[TBL] [Abstract][Full Text] [Related]
14. Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19.
Eichhorn T; Weiss R; Huber S; Ebeyer-Masotta M; Mostageer M; Emprechtinger R; Knabl L; Knabl L; Würzner R; Weber V
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069209
[TBL] [Abstract][Full Text] [Related]
15. Depletion of abundant plasma proteins for extracellular vesicle proteome characterization: benefits and pitfalls.
Reymond S; Gruaz L; Sanchez JC
Anal Bioanal Chem; 2023 Jul; 415(16):3177-3187. PubMed ID: 37069444
[TBL] [Abstract][Full Text] [Related]
16. The Proteome of Large or Small Extracellular Vesicles in Pig Seminal Plasma Differs, Defining Sources and Biological Functions.
Barranco I; Sanchez-López CM; Bucci D; Alvarez-Barrientos A; Rodriguez-Martinez H; Marcilla A; Roca J
Mol Cell Proteomics; 2023 Apr; 22(4):100514. PubMed ID: 36796643
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
19. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform.
Rai A; Fang H; Claridge B; Simpson RJ; Greening DW
J Extracell Vesicles; 2021 Nov; 10(13):e12164. PubMed ID: 34817906
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Size Exclusion Chromatography for Extracellular Vesicle Enrichment and Proteomic Analysis from Clinically Relevant Samples.
Lane RE; Korbie D; Trau M; Hill MM
Proteomics; 2019 Apr; 19(8):e1800156. PubMed ID: 30632691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
